跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbesaph-300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbesaph-300
Approved
STANDARD
Irbesaph-300
Sai Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0a099a0766348eab
Company
Sai Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
0a099a0766348eab
Drug Approval Philippines Name
Irbesaph-300
Product Name
Irbesaph-300
Registration Number
DRP-15388
Brand Name
Irbesaph-300
Generic Name
Irbesartan
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Sai Parenterals Ltd.
Importer
Ollen Pharma Trading Inc.
Distributor
Ollen Pharma Trading Inc.
Issuance Date
29 April 2025
Expiry Date
29 April 2030
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0a099a0766348eab
Type
Standard
Back to Philippines FDA Approvals